Andy Leitch

Track

Insider profile

Currently holds positions in Blackbaud Inc, Gene Biotherapeutics Inc and STR Holdings Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Blackbaud Inc July 1, 2009 -
Independent Director Gene Biotherapeutics Inc Aug. 14, 2007 -
Independent Director STR Holdings Inc Nov. 6, 2009 -
Andy Leitch's trades of Blackbaud Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Blackbaud Inc (BLKB)
Transaction date
Sale
Price
149.43
Quantity 26,992 -23.6%
Value US$1,671,644
US Blackbaud Inc (BLKB)
Transaction date
Sale
Price
67.23
Quantity 64,100 -17.3%
Value US$1,090,411
US Blackbaud Inc (BLKB)
Transaction date
Sale
Price
296.49
Quantity 16,441 +34.1%
Value US$1,726,690
US Blackbaud Inc (BLKB)
Transaction date
Sale
Price
81.33
Quantity 3,449 -12.6%
Value US$280,507
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-24 2022-05-20
US Blackbaud Inc (BLKB)
S Sale
26,992 -23.6%
149.43
US$1,671,644 		26,992 -23.6% 149.43 US$1,671,644
2022-05-24 2022-05-20
US Blackbaud Inc (BLKB)
S Sale
64,100 -17.3%
67.23
US$1,090,411 		64,100 -17.3% 67.23 US$1,090,411
2022-05-24 2022-05-20
US Blackbaud Inc (BLKB)
S Sale
16,441 +34.1%
296.49
US$1,726,690 		16,441 +34.1% 296.49 US$1,726,690
2019-11-14 2019-11-12
US Blackbaud Inc (BLKB)
S Sale
3,449 -12.6%
81.33
US$280,507 		3,449 -12.6% 81.33 US$280,507